A Phase 1b2a Trial of a Halflife Extended Respiratory Syncytial Virus Neutralizing Antibody Clesrovimab in Healthy Preterm and Fullterm Infants

Simple item page
dc.article.end-page487en
dc.article.start-page478en
dc.citation.doi10.1093/INFDIS/JIAE581en
dc.contributor.authorShabir Madhien
dc.contributor.authorE Simõesen
dc.contributor.authorA Acevedo-Quiñonesen
dc.contributor.authorJ Pizarroen
dc.contributor.authorS Sheparden
dc.contributor.authorE et alen
dc.date.accessioned2026-04-07T17:44:55Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0022-1899en
dc.identifier.urihttps://hdl.handle.net/10539/48912
dc.journal.titleA Phase 1b2a Trial of a Halflife Extended Respiratory Syncytial Virus Neutralizing Antibody Clesrovimab in Healthy Preterm and Fullterm Infantsen
dc.journal.volume231en
dc.titleA Phase 1b2a Trial of a Halflife Extended Respiratory Syncytial Virus Neutralizing Antibody Clesrovimab in Healthy Preterm and Fullterm Infantsen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
566.52 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)